The company currently offers its products to a market of over 42 million people. Arriani Pharmaceuticals S.A. maintains an international outlook, trading products in Greece, Cyprus, Bulgaria and Romania. Its future plans include gradual expansion to Turkey, Croatia, Slovenia, Bosnia, Herzegovina, Serbia, Montenegro,
F.Y.R.O.Macedonia and Albania.

Successfully trading innovative products, Arriani Pharmaceuticals S.A. has earned significant expertise in pharmaceutical marketing. In-depth knowledge of the regional market, excellent know-how of clinical and regulatory requirements across Southeastern Europe, an extensive network of associates and a competent sales team allow us to stay at the forefront of a highly competitive environment and contribute to our partners’ growth.

Besides licensing innovative pharmaceuticals, the company offers its partners the opportunity to carry out in Greece phase III clinical trials that advance the development of their new products. Furthermore, Arriani Pharmaceuticals S.A. sponsors and organizes educational seminars, lectures, hands-on courses and Post-Graduate programs in several medical fields, in collaboration with select Greek Universities.